Angle (AGL)

Sector:

Support

Index:

FTSE AIM All-Share

14.63p
   
  • Change Today:
      0.38p
  • 52 Week High: 31.35
  • 52 Week Low: 9.24
  • Currency: UK Pounds
  • Shares Issued: 322.64m
  • Volume: 656,894
  • Market Cap: £47.19m
  • RiskGrade: 312

Latest ShareCast News

Angle unveils plans to raise more than £10m

By Abigail Townsend

Date: Wednesday 05 Jun 2024

(Sharecast News) - Liquid biopsy specialist Angle is to raise more than £10m to support future growth, the UK company announced on Wednesday.

Angle reports promising results from Parsortix study

By Benjamin Chiou

Date: Thursday 16 May 2024

(Sharecast News) - Angle, the AIM-listed liquid biopsy company which specialises in circulating tumour cell (CTC) solutions, has announced the results of a clinical study which show that its Parsortix system could be used to predict progression-free survival in patients with ovarian cancer.

Angle strikes supplier deal with AstraZeneca

By Iain Gilbert

Date: Friday 03 May 2024

(Sharecast News) - Liquid biopsy technology firm Angle has struck a supplier deal with pharmaceutical giant AstraZeneca to develop an androgen receptor detection assay to enhance prostate cancer studies.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Angle Market Data

Currency UK Pounds
Share Price 14.63p
Change Today 0.38p
% Change 2.63 %
52 Week High 31.35
52 Week Low 9.24
Volume 656,894
Shares Issued 322.64m
Market Cap £47.19m
RiskGrade 312

Angle Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.58% below the market average47.58% below the market average47.58% below the market average47.58% below the market average47.58% below the market average
8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average
Price Trend
66.04% below the market average66.04% below the market average66.04% below the market average66.04% below the market average66.04% below the market average
71.72% below the sector average71.72% below the sector average71.72% below the sector average71.72% below the sector average71.72% below the sector average
Income Not Available
Growth
54.57% above the market average54.57% above the market average54.57% above the market average54.57% above the market average54.57% above the market average
57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Angle Dividends

No dividends found

Trades for 26-Jul-2024

Time Volume / Share Price
17:05 10,000 @ 14.63p
16:29 34,917 @ 14.32p
16:28 34,768 @ 14.38p
16:25 10,000 @ 14.47p
16:16 34,805 @ 14.38p

Angle Key Personnel

CEO Andrew D Newland
Finance Director Ian F Griffiths
Chair Jan Groen

Top of Page